Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
4.260
-1.220 (-22.26%)
At close: Dec 5, 2025, 4:00 PM EST
4.840
+0.580 (13.62%)
After-hours: Dec 5, 2025, 7:54 PM EST
Predictive Oncology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 1.66 | 1.62 | 1.63 | 1.51 | 1.42 | 1.25 | Upgrade
|
| Revenue Growth (YoY) | 320.71% | -0.24% | 8.12% | 5.97% | 13.45% | -11.29% | Upgrade
|
| Cost of Revenue | 0.85 | 0.83 | 0.61 | 0.51 | 0.49 | 0.45 | Upgrade
|
| Gross Profit | 0.81 | 0.8 | 1.02 | 1 | 0.93 | 0.81 | Upgrade
|
| Selling, General & Admin | 11.77 | 11.74 | 13.14 | 16.27 | 14.41 | 13.29 | Upgrade
|
| Operating Expenses | 11.77 | 11.74 | 13.14 | 16.27 | 14.41 | 13.29 | Upgrade
|
| Operating Income | -10.96 | -10.94 | -12.12 | -15.27 | -13.47 | -12.48 | Upgrade
|
| Interest Expense | -0.06 | - | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -73.6 | 0.08 | 0.1 | 0.31 | 0.12 | -0.36 | Upgrade
|
| EBT Excluding Unusual Items | -84.62 | -10.86 | -12.02 | -14.96 | -13.36 | -12.84 | Upgrade
|
| Impairment of Goodwill | - | - | - | -7.23 | -2.81 | -12.88 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | -0 | -0 | -0.01 | -0.01 | - | Upgrade
|
| Asset Writedown | - | - | - | -3.53 | -4.14 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -0.16 | Upgrade
|
| Pretax Income | -84.62 | -10.86 | -12.02 | -25.74 | -20.32 | -25.88 | Upgrade
|
| Income Tax Expense | - | - | - | - | -0.66 | - | Upgrade
|
| Earnings From Continuing Operations | -84.62 | -10.86 | -12.02 | -25.74 | -19.66 | -25.88 | Upgrade
|
| Earnings From Discontinued Operations | 0.29 | -1.8 | -1.97 | - | - | - | Upgrade
|
| Net Income | -84.33 | -12.66 | -13.98 | -25.74 | -19.66 | -25.88 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.55 | Upgrade
|
| Net Income to Common | -84.33 | -12.66 | -13.98 | -25.74 | -19.66 | -26.44 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 76.22% | 35.84% | 8.92% | 34.34% | 359.21% | - | Upgrade
|
| EPS (Basic) | -149.54 | -34.83 | -52.25 | -104.74 | -107.46 | -663.72 | Upgrade
|
| EPS (Diluted) | -149.54 | -34.83 | -52.25 | -104.74 | -108.00 | -663.72 | Upgrade
|
| Free Cash Flow | -7.89 | -11.97 | -13.21 | -12.79 | -13.12 | -12.56 | Upgrade
|
| Free Cash Flow Per Share | -13.99 | -32.91 | -49.36 | -52.05 | -71.72 | -315.21 | Upgrade
|
| Gross Margin | 48.91% | 49.12% | 62.57% | 66.45% | 65.72% | 64.29% | Upgrade
|
| Operating Margin | -658.44% | -673.69% | -744.47% | -1014.16% | -948.25% | -996.87% | Upgrade
|
| Profit Margin | -5066.96% | -779.91% | -859.13% | -1709.62% | -1383.64% | -2111.26% | Upgrade
|
| Free Cash Flow Margin | -473.98% | -736.86% | -811.63% | -849.62% | -923.46% | -1002.67% | Upgrade
|
| EBITDA | -10.8 | -10.78 | -11.87 | -13.95 | -12.13 | -11.46 | Upgrade
|
| D&A For EBITDA | 0.16 | 0.16 | 0.24 | 1.31 | 1.34 | 1.02 | Upgrade
|
| EBIT | -10.96 | -10.94 | -12.12 | -15.27 | -13.47 | -12.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.